aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 5.53 USD 6.55% Market Closed
Market Cap: 492.2m USD
Have any thoughts about
aTyr Pharma Inc?
Write Note

Wall Street
Price Targets

ATYR Price Targets Summary
aTyr Pharma Inc

Wall Street analysts forecast ATYR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATYR is 18.3 USD with a low forecast of 9.09 USD and a high forecast of 36.75 USD.

Lowest
Price Target
9.09 USD
64% Upside
Average
Price Target
18.3 USD
231% Upside
Highest
Price Target
36.75 USD
565% Upside
aTyr Pharma Inc Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
33% Upside
SRZN
Surrozen Inc
354% Upside
87S
Roivant Sciences Ltd
67% Upside
HUMA
Humacyte Inc
279% Upside
BMRN
Biomarin Pharmaceutical Inc
64% Upside
MAB
Mabion SA
6% Downside
BSLN
Basilea Pharmaceutica AG
89% Upside
ZNTL
Zentalis Pharmaceuticals Inc
353% Upside

Revenue
Forecast

Revenue Estimate
aTyr Pharma Inc

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 3 years is 747%.

N/A
Past Growth
747%
Estimated Growth
Estimates Accuracy
20%
Average Beat

Operating Income
Forecast

Operating Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATYR's stock price target?
Price Target
18.3 USD

According to Wall Street analysts, the average 1-year price target for ATYR is 18.3 USD with a low forecast of 9.09 USD and a high forecast of 36.75 USD.

What is aTyr Pharma Inc's Revenue forecast?
Projected CAGR
747%

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 3 years is 747%.

Back to Top